How Adageis Simplifies Value-Based Care, Boosting Revenue for Healthcare Providers

• Adageis streamlines complex insurance contracts, helping providers maximize reimbursements.
• The company’s AI-driven solutions reduce administrative burden, freeing up time for patient care.
• Seamless integration with nearly 100 EHR systems ensures a smooth transition to value-based care models.
• The company’s fintech approach enhances financial performance, with providers seeing up to $75,000 in additional revenue.
• Adageis projects significant growth, expecting to cover 580,000 patient lives by mid-2025.

Healthcare is shifting toward value-based care, where providers are reimbursed for patient outcomes rather than the number of procedures performed. While the model promises higher-quality care at lower costs, it also introduces complex reimbursement structures that can be difficult to navigate.

Adageis, a healthcare technology company providing smart AI-centric software solutions for healthcare organizations, is helping providers optimize care delivery while maximizing revenue. The company’s AI-driven platform integrates with nearly 100 electronic health record (“EHR”) systems, making it easy for medical practices to track performance metrics and meet insurers’ evolving documentation requirements.

“One of the major challenges in the marketplace is the sheer complexity — there are over 100 insurance companies with more than 1,000 plans in the Phoenix area alone. Each has different measures and unique documentation requirements… Adageis has a solution that integrates with nearly 100 electronic health record systems, overlaying existing platforms to provide easy-to-read measures tailored to each patient’s insurance,” Adageis CEO Shane Speirs said during a recent podcast (https://ibn.fm/7yFnW).

According to Speirs, what Adageis focuses on is to provide a simple solution to healthcare organizations — ranging from large, multi-state, multi-specialty healthcare groups to independent practices across the country. “We offer a solution that meets everyone’s needs, helping providers and organizations drive revenue by delivering high-quality care, which everyone can align with,” the Adageis CEO said. “Much of the value in value-based care comes from providing proper documentation to patients and being proactive with screenings. We provide an easy solution for practices to indicate the metrics needed for patients, to provide high-quality care while maximizing incentive dollars.”

Another issue the healthcare system is facing is the fact that administrative tasks, such as clinical documentation and coding, consume valuable time that could be spent on patient care. Adageis addresses this issue with its AI Scribe technology, which uses ambient listening to automate documentation and coding. By leveraging AI, the platform:

• Reduces administrative workload, allowing providers to focus on patient care.
• Generates high-quality coding, ensuring maximum reimbursement.
• Minimizes errors in documentation, lowering the risk of rejected claims.

This approach enhances financial performance, with some providers seeing up to $75,000 in additional annual revenue from value-based care incentives, according to figures listed in the company’s investor deck.

Adageis is positioning itself as a leader in healthcare fintech, as the only healthcare fintech company in the marketplace, bridging the gap between financial optimization and improved patient care. The company’s growth projections underscore its increasing market presence:

• Currently covering 150,000 patient lives, with plans to reach 580,000 by mid-2025.
• $100,000 in monthly recurring revenue expected by Q2 2025.
• Expanding provider base, onboarding 2-3 new clients per month.

By integrating financial technology with AI-driven healthcare solutions, Adageis is reshaping how providers approach value-based care, ensuring better patient outcomes while driving revenue growth. Allowing providers to simplify complex financial structures while maintaining quality care, Adageis offers a scalable, easy-to-implement platform, reducing inefficiencies and ensuring forward-thinking providers thrive in a rapidly evolving landscape.

For more information, visit the company’s website at www.Adageis.com.

NOTE TO INVESTORS: The latest news and updates relating to Adageis are available in the company’s newsroom at https://ibn.fm/Adageis

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN